Access to cardiovascular medicines in low- and middle-income countries: a mini review

[1] Bazargani YT(2014)Essential medicines are more available than other medicines around the globe PLoS ONE 9 2076-2085

[2] Ewen M(2016)Access to medications for cardiovascular diseases in low-and middle-income countries Circulation 133 e411-e419

[3] de Boer A(2017)Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data Lancet Public Health 2 e0171284-9

[4] Leufkens HG(2017)Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases PLoS ONE 12 1-288

[5] Mantel-Teeuwisse AK(2021)Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in Ghana Pan African Med J. 10 279-2

[6] Wirtz VJ(2010)Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data BMC Cardiovasc Disord 85 e015302-69

[7] Kaplan WA(2007)The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries Bull World Health Organ 9 e002640-8

[8] Kwan GF(2020)Access to cardiovascular disease and hypertension medicines in developing countries: an analysis of essential medicine Lists, price, availability, and affordability J Am Heart Assoc 5 175-11052

[9] Laing RO(2020)Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries BMJ Glob Health 18 e040908-146

[10] Attaei MW(2021)Availability of essential medicines in a country in conflict: a quantitative insight from Yemen Int J Environ Res Public Health 10 1-720

[1] Bazargani YT(2014)Essential medicines are more available than other medicines around the globe PLoS ONE 9 2076-2085

[2] Ewen M(2016)Access to medications for cardiovascular diseases in low-and middle-income countries Circulation 133 e411-e419

[3] de Boer A(2017)Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data Lancet Public Health 2 e0171284-9

[4] Leufkens HG(2017)Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases PLoS ONE 12 1-288

[5] Mantel-Teeuwisse AK(2021)Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in Ghana Pan African Med J. 10 279-2

[6] Wirtz VJ(2010)Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data BMC Cardiovasc Disord 85 e015302-69

[7] Kaplan WA(2007)The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries Bull World Health Organ 9 e002640-8

[8] Kwan GF(2020)Access to cardiovascular disease and hypertension medicines in developing countries: an analysis of essential medicine Lists, price, availability, and affordability J Am Heart Assoc 5 175-11052

[9] Laing RO(2020)Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries BMJ Glob Health 18 e040908-146

[10] Attaei MW(2021)Availability of essential medicines in a country in conflict: a quantitative insight from Yemen Int J Environ Res Public Health 10 1-720